Significantly, C3 and terminal complement component deposition is also found in coronary arteries of patients with systemic inflammatory diseases including lupus erythematosus and rheumatoid arthritis, and this was proposed as an underlying mechanism of accelerated coronary artery disease known to occur in these patients [23,24]. Here, C3 is linked to lupus erythematosus.